NCT02634385

Brief Summary

Laparoscopic partial nephrectomy (LPN) is often reserved for patients with a small peripheral tumour, in the hands of an experienced surgeon since it demands a high degree of endoscopic skill. Renal vessel clamp for vascular control is a required step during standard LPN. However, this creates a time limiting step for the surgeon and induces renal injury via warm ischemia and reperfusion injury. This novel approach can substantially reduce renal injury during LPN via superselective embolization of level II renal arteries pre-operatively. This technique facilitates the performance of a clamp-less, zero-ischemia LPN, significantly simplifying the procedure by remove time thresholds within which to perform tumor excision. The preliminary results are promising; however, there is a need for further corroboration of their results, in addition to a randomized controlled trial comparing this modified, zero ischemia technique with standard LPN.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2015

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2014

Completed
1.1 years until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 18, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

July 27, 2016

Status Verified

July 1, 2016

Enrollment Period

5 months

First QC Date

October 10, 2014

Last Update Submit

July 26, 2016

Conditions

Outcome Measures

Primary Outcomes (3)

  • Extirpative time

    From initial renal tissue breach until completion of bolster placement. Calculated in minutes.

    Duration of Surgical Procedure

  • Warm ischemia time

    From renal vessel clamping to unclamping during nephrectomy (only if clamping has occurred). Calculated in minutes.

    Duration of Surgical Procedure

  • Mean estimated blood loss (measured in ml)

    From the start of procedure (Nephrectomy), until the end of the procedure.

    Duration of Surgical Procedure

Secondary Outcomes (6)

  • Mean hospital stay

    2-10 Days

  • Blood transfusions

    From date of pre-op up to 6 months post-op

  • Conversion to other type of surgery (i.e. Radical Nephrectomy)

    Duration of Surgical Procedure

  • Identification of other complications (i.e. readmission, arteriovenous malformations)

    Up to 24 months post-operatively.

  • Overall survival rates

    Up to 24 months post-operatively.

  • +1 more secondary outcomes

Study Arms (1)

Small Renal Mass

NO INTERVENTION

Patient's with a small renal mass will be undergoing embolization prior to laparoscopic partial nephrectomy.

Procedure: Renal Artery EmbolizationProcedure: Partial Nephrectomy (Surgical Resection)

Interventions

Patients will be receiving embolization prior to planned partial nephrectomy.

Small Renal Mass

Patients will be undergoing planned partial nephrectomy post embolization.

Small Renal Mass

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • T1a renal cell carcinomas diagnosed by ultrasonography (US), computed tomography (CT) or fine needle aspiration
  • tumor size \<4cm in diameter
  • predominant exophytic growth
  • intraparenchymal depth no greater than 1.5cm, with a minimum distance of 5mm from the urinary collecting system

You may not qualify if:

  • predominant endophytic nature (depth \</= 1.5 cm)
  • nearness (\<0.5cm) of the tumor to the urinary collecting system
  • multiple ipsilateral lesions
  • pregnancy
  • allergy to intravenous contrast dye
  • absolute contraindications to surgical intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Joseph's Healthcare Hamilton - McMaster Institute of Urology

Hamilton, Ontario, L8N4A6, Canada

Location
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, FRCSC

Study Record Dates

First Submitted

October 10, 2014

First Posted

December 18, 2015

Study Start

November 1, 2015

Primary Completion

April 1, 2016

Study Completion

June 1, 2016

Last Updated

July 27, 2016

Record last verified: 2016-07

Locations